Viewing Study NCT01226225



Ignite Creation Date: 2024-05-05 @ 10:58 PM
Last Modification Date: 2024-10-26 @ 10:26 AM
Study NCT ID: NCT01226225
Status: UNKNOWN
Last Update Posted: 2010-11-10
First Post: 2010-08-19

Brief Title: A Multicentre Trial on the Effectiveness of Physical Rehabilitation of Patients With Coronary Artery Disease Aerobic Interval Training Versus Moderate Continuous Training
Sponsor: University Hospital Antwerp
Organization: University Hospital Antwerp

Study Overview

Official Title: None
Status: UNKNOWN
Status Verified Date: 2010-08
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SAINTEX-CAD
Brief Summary: Cardiac rehabilitation including physical training has become accepted treatment following myocardial infarction coronary stent implantation and coronary bypass operation Besides modifying patients risk profile for future coronary problems the focus is on improving exercise capacity The ability to be able to perform at a higher maximal level is a strong predictor for outcome new cardiovascular events and mortality The main purpose of this study is to evaluate whether aerobic interval training outweighs more classical moderate endurance training in improving exercise capacity During interval training patients perform exercise at high intensity but for only a couple of minutes and then recover at a lower intensity Such intervals are repeated Preliminary evidence from smaller studies suggests that this type of training leads to a larger increase in exercise capacity compared to the more traditional endurance training at moderate intensity

In addition mechanisms that might explain how this improvement is achieved as well as safety and impact on quality of life will be studied
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None